KIF18B Inhibitors

KIF18B inhibitors represent a group of chemical compounds that are poised to modulate the activity or expression of the kinesin-like protein KIF18B, a member of the extensive kinesin superfamily of motor proteins. KIF18B plays a fundamental role in the modulation of microtubule dynamics, especially during mitosis. Given the importance of microtubules in cellular processes, accurate regulation is vital. The role of KIF18B, particularly in conjunction with other proteins like KIF2C, is pivotal in ensuring proper microtubule dynamics, as they together constitute the major microtubule plus-end depolymerizing activity in mitotic cells. This crucial interaction ensures accurate chromosome alignment and segregation, emphasizing the importance of finely-tuned microtubule dynamics in cell health and integrity. The compounds listed as KIF18B inhibitors, such as paclitaxel, vinblastine, and colchicine, to name a few, generally exert their effects by targeting microtubules or associated processes. For instance, paclitaxel stabilizes microtubules, preventing their depolymerization, while vinblastine and colchicine inhibit microtubule formation and polymerization, respectively. The hypothesis is that by modulating microtubule dynamics, these compounds could indirectly influence the function or expression of KIF18B. In essence, the landscape on which KIF18B acts, i.e., the microtubules, is altered, which can lead to changes in KIF18B's activity or expression.